SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-04-219783
Filing Date
2004-12-28
Accepted
2004-12-27 21:52:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.htm SC 13D 63587
2 AGREEMENT AND PLAN OF MERGER dex991.htm EX-99.1 536814
3 POWER OF ATTORNEY dex996.htm EX-99.6 3152
  Complete submission text file 0001193125-04-219783.txt   605791
Mailing Address 401 WILSHIRE BOULEVARD SUITE 1020 SANTA MONICA CA 90401
Business Address 401 WILSHIRE BOULEVARD SUITE 1020 SANTA MONICA CA 90401 310-526-5000
ORION ACQUISITION CORP II (Subject) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-53711 | Film No.: 041227389
SIC: 6770 Blank Checks

Mailing Address 167 SKYVIEW WAY SAN FRANCISCO CA 94131
Business Address 167 SKYVIEW WAY SAN FRANCISCO CA 94131 4159904761
Selena Pharmeceuticals Inc (Filed by) CIK: 0001311211 (see all company filings)

IRS No.: 943308634 | State of Incorp.: CA | Fiscal Year End: 1231